Dividend Channel
Free Dividend Report - Top Ranked Stocks

PARTNER NEWS:

Wed, Apr 17, 9:02 AM, Zacks
2seventy bio (TSVT) Rises More Than 50% in 3 Months: Here's Why
The FDA's recent nod to 2seventy bio's (TSVT) Abecma in earlier lines of treatment for relapsed/refractory multiple myeloma is a positive. Also, the R&D asset divestiture to Regeneron is saving costs.

Wed, Apr 17, 6:50 AM, Zacks
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Featured MNV Articles:

Analysts Expect 10% Upside For The Holdings of XSMO
Thursday, April 18, 6:34 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

5 Dividend Aristocrats Where Analysts See Capital Gains
Thursday, April 18, 6:34 AM ET, by Market News Video Staff

To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently ...

Model N Reaches Analyst Target Price
Thursday, April 18, 6:34 AM ET, by Market News Video Staff

In recent trading, shares of Model N, Inc (MODN) have crossed above the average analyst ...

Analysts See 11% Gains Ahead For The Holdings of EPS
Thursday, April 18, 6:34 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Analysts Anticipate NAIL Will Reach $115
Thursday, April 18, 6:34 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
Play Video: The Importance of ETFs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts


Dividend Channel | www.DividendChannel.com | Copyright © 2010 - 2024, All Rights Reserved

Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.